CardioLogs ECG Analysis Platform vs eMurmur Heart AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CardioLogs (acquired by Philips in 2021)
VS
by eMurmur

AI Verdict

Tool A specializes in AI-powered analysis of ECG data for arrhythmia detection, compatible with various cardiac monitoring devices. Tool B, on the other hand, focuses on automated analysis of heart and lung sounds from stethoscopes to detect murmurs and provide hemodynamic insights. While both are AI-driven cardiac diagnostic tools, they process different physiological signals and address distinct aspects of cardiac assessment, making them complementary rather than direct substitutes.

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your primary need is rapid, AI-powered analysis of electrocardiogram (ECG) data from various cardiac monitoring devices to accurately detect and diagnose a wide range of arrhythmias. This platform is ideal for practices requiring deep neural network analysis and cloud-based efficiency for comprehensive arrhythmia management and reporting.

View CardioLogs ECG Analysis Platform →

Choose eMurmur Heart AI if…

Choose eMurmur Heart AI if your focus is on leveraging AI for automated analysis of heart and lung sounds, particularly for detecting and classifying murmurs and gaining hemodynamic insights. This tool is best suited for scenarios involving digital stethoscope integration, telehealth, and remote monitoring where auscultation data needs to be recorded, analyzed, and compared over time.

View eMurmur Heart AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform eMurmur Heart AI
Pricing Unknown Contact for quote
Deployment Cloud-based Web-based, Mobile App, API integration
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eMurmur Heart AI

Tool B offers a highly flexible platform with mobile apps (iOS, Android), a web portal, and hardware-neutral compatibility for stethoscopes, supporting live streaming and remote auscultation. This broad accessibility and adaptability across various devices and clinical settings give it an edge in usability compared to Tool A's cloud-based ECG analysis, though Tool A also offers EHR integration and multi-device compatibility.

Clinical Value

Tie

Both tools are FDA-cleared and provide significant clinical value in their respective specialized domains. Tool A excels in AI-powered ECG analysis for arrhythmia detection, while Tool B provides automated analysis of heart and lung sounds, detecting murmurs and offering hemodynamic insights. Their distinct focuses mean neither can be definitively declared superior in overall clinical value without specific comparative studies across different diagnostic needs.

Pricing & Value

CardioLogs ECG Analysis Platform

Tool A offers a more transparent pricing model with a 'pay per ECG' structure, providing a clearer basis for cost estimation and budgeting. In contrast, Tool B's pricing is listed as 'contact for pricing,' which offers less transparency and predictability for potential customers.

Enterprise Readiness

CardioLogs ECG Analysis Platform

Tool A, as a Philips solution, benefits significantly from the backing of a major global healthcare technology company, implying robust enterprise-grade infrastructure, sales channels, and established trust. While Tool B meets essential compliance requirements like HIPAA and FDA clearance, its smaller company size (CSD Labs) suggests a potentially less extensive enterprise support and integration ecosystem compared to a Philips-backed product.

Innovation

eMurmur Heart AI

Tool B demonstrates greater innovation by applying AI to the traditionally manual process of auscultation, including analysis of both heart and lung sounds, providing hemodynamic insights, and enabling live streaming/remote auscultation. While Tool A's deep neural networks for ECG analysis are advanced, Tool B's approach pushes the boundaries in a less digitized diagnostic area, offering novel capabilities for remote care and comprehensive sound analysis.

Support & Docs

CardioLogs ECG Analysis Platform

As a Philips solution, Tool A benefits from Philips' extensive global support infrastructure and established documentation practices, which are typically comprehensive for enterprise clients. While Tool B (CSD Labs) likely offers support, the scale and breadth of support and documentation from a major vendor like Philips are generally more robust and readily available.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform eMurmur Heart AI
Company Cardiologs Technologies (now part of Philips) CSD Labs
Primary Analysis Focus ECG data (arrhythmia detection) Heart and lung sounds (murmur detection, hemodynamic insights)
AI Technology AI-Powered ECG Analysis (Deep Neural Networks) Automated heart and lung sound analysis (S1, S2, murmurs, crackles, wheezes)
Device Compatibility Multi-Device Compatibility (Holter, smartwatches, ECG patches) Hardware-neutral and stethoscope agnostic platform compatibility
Supported Medical Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Internal Medicine, Pulmonology
Telehealth/Remote Capabilities Real-Time Monitoring/Analysis Live streaming and remote auscultation for telehealth, Recording, secure storage, and playback of auscultation data, Comparison of current and previous auscultation data for monitoring

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and eMurmur Heart AI.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

CardioLogs ECG Analysis Platform specializes in analyzing ECG data from various cardiac monitoring devices to detect arrhythmias. In contrast, eMurmur Heart AI focuses on the automated analysis of heart and lung sounds to detect murmurs and provide hemodynamic insights.
CardioLogs ECG Analysis Platform is designed for automated arrhythmia detection, including conditions like AFib and VT, from ECG data. eMurmur Heart AI detects and classifies pathologic and innocent heart murmurs and offers hemodynamic insights such as loudness ratios of S1, systole, S2, and diastole.
CardioLogs ECG Analysis Platform is compatible with various cardiac monitoring devices, such as Holter monitors, smartwatches, and ECG patches. eMurmur Heart AI is hardware-neutral and stethoscope agnostic, supporting digital stethoscopes for heart and lung sound acquisition.
CardioLogs ECG Analysis Platform provides real-time monitoring and analysis of ECG data. eMurmur Heart AI supports live streaming and remote auscultation for telehealth, along with recording and secure storage of auscultation data.
Both platforms serve Cardiology and Internal Medicine. Additionally, CardioLogs ECG Analysis Platform is relevant for Emergency Medicine, while eMurmur Heart AI extends its utility to Pulmonology due to its lung sound analysis capabilities.
AI Tool Finder
AI-powered search. Results may not be comprehensive.